It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2015-2016. During the financial year, The Company’s revenues grew by 4% over the previous year to Rs. 154.7 billion. EBITDA was more or less unchanged at Rs. 36.3 billion and accounted for 23.4% of consolidated revenues. Profit before Tax (PBT) was 4% less at Rs. 27.1 billion, 17.5% of revenues. Profit after Tax (PAT) for the year was 10% less at Rs. 20 billion, 12.9% of revenues.
The Board of Directors of the Company has proposed a dividend of Rs. 20/- per equity share of Rs. 5/-.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
